Skip to main content
Recall Canary
MG217 Multi-Symptom Treatment Cream
← Back to all recalls
DRUG RECALLCRITICAL

MG217 Multi-Symptom Treatment Cream

MG217 Multi-Symptom Treatment Cream recalled due to Staphylococcus aureus contamination.

What to do

Stop using the recalled MG217 Multi-Symptom Treatment Cream immediately. Return the product to the place of purchase for a refund. Contact Wisconsin Pharmacal Company for further instructions.

Recalled
Listed
Updated
Recall No.
D-0553-2026
Agency
FDA
Firm
Wisconsin Pharmacal Company
Recall ID
98788
Status
ONGOING

Recall at a glance

Quantity recalled
690 tubes

Why it was recalled

Wisconsin Pharmacal Company is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) in 6 oz (170 g) tubes due to confirmed microbial contamination with Staphylococcus aureus. Consumers should stop using the product immediately and return it to the place of purchase for a refund.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube

Lot code
1024088
Best-by
November 2026
UPC
012277051067

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-04 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification